SIGNE BIOPHARMA INC has a total of 12 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), Canada and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CHANGCHUN SR BIOLOGICAL TECH CO LTD, INST OF MILITARY VETERINARY MEDICINE ACADEMY OF MILITARY SCIENCES and BEIJING ZHONGHAI BIOTECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | Canada | 2 | |
#3 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Sirbasku David A | 12 |
Publication | Filing date | Title |
---|---|---|
EP1490502A2 | Screening method for predicting susceptibility to breast cancer | |
EP2299265A1 | Cancer eradication program | |
US7947275B2 | Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth | |
CA2804977A1 | Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth |